Listed

Bioventus Inc.

BVSNasdaqCIK 1665988HealthcareFiscal year ends Dec 31

Reports and events: 114 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Bioventus Inc., Reports and events
FiledFormWhat it isAccession number
2021-07-1416:14 ET8-K5.02 Departure or appointment of officers or directors0001628280-21-013829
2021-05-1308:59 ET10-QQuarterly reportPeriod 2021-04-030001628280-21-010090
2021-05-1216:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-21-010016
2021-03-3118:26 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-100715
2021-03-2918:24 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-096828
2021-03-2616:13 ET10-KAnnual reportPeriod 2020-12-310001628280-21-005771
2021-02-1707:41 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-045802
2021-02-1008:33 ETS-1/ARegistration statement, amended0001193125-21-035490
2021-02-0407:02 ETS-1/ARegistration statement, amended0001193125-21-028021
2021-01-2018:54 ETS-1Registration statement0001193125-21-011667
2016-07-2717:05 ETS-1/ARegistration statement, amended0001193125-16-660212
2016-07-2516:20 ETS-1/ARegistration statement, amended0001193125-16-656567
2016-07-1906:33 ETS-1/ARegistration statement, amended0001193125-16-650677
2016-06-3009:50 ETS-1Registration statement0001193125-16-637577

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 17:43 ET. Listed shows no prices and gives no investment advice.